Literature DB >> 18546618

Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium.

Andrew Berchuck1, Joellen M Schildkraut, C Leigh Pearce, Georgia Chenevix-Trench, Paul D Pharoah.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18546618     DOI： 10.1007/978-0-387-68969-2_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  17 in total

Review 1.  The inherited genetics of ovarian and endometrial cancer.

Authors:  Simon A Gayther; Paul D P Pharoah
Journal:  Curr Opin Genet Dev       Date:  2010-04-24       Impact factor: 5.578

2.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

3.  Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.

Authors:  Holly R Harris; Ana Babic; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Francesmary Modugno; Roberta B Ness; Kirsten B Moysich; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Elisa V Bandera; Nicolas Wentzensen; Joanne Kotsopoulos; Steven A Narod; Catherine M Phelan; John R McLaughlin; Hoda Anton-Culver; Argyrios Ziogas; Celeste L Pearce; Anna H Wu; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

Review 4.  Ovarian cancer epidemiology in the era of collaborative team science.

Authors:  Rikki A Cannioto; Britton Trabert; Elizabeth M Poole; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-03-10       Impact factor: 2.506

5.  Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.

Authors:  Catherine M Phelan; Ya-Yu Tsai; Ellen L Goode; Robert A Vierkant; Brooke L Fridley; Jonathan Beesley; Xiao Qing Chen; Penelope M Webb; Stephen Chanock; Daniel W Cramer; Kirsten Moysich; Robert P Edwards; Jenny Chang-Claude; Montserrat Garcia-Closas; Hannah Yang; Shan Wang-Gohrke; Rebecca Hein; Adele C Green; Jolanta Lissowska; Michael E Carney; Galina Lurie; Lynne R Wilkens; Roberta B Ness; Celeste Leigh Pearce; Anna H Wu; David J Van Den Berg; Daniel O Stram; Kathryn L Terry; David C Whiteman; Alice S Whittemore; Richard A DiCioccio; Valerie McGuire; Jennifer A Doherty; Mary Anne Rossing; Hoda Anton-Culver; Argyrios Ziogas; Claus Hogdall; Estrid Hogdall; Susanne Krüger Kjaer; Jan Blaakaer; Lydia Quaye; Susan J Ramus; Ian Jacobs; Honglin Song; Paul D P Pharoah; Edwin S Iversen; Jeffrey R Marks; Malcolm C Pike; Simon A Gayther; Julie M Cunningham; Marc T Goodman; Joellen M Schildkraut; Georgia Chenevix-Trench; Andrew Berchuck; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

6.  Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk.

Authors:  Galina Lurie; Kathryn L Terry; Lynne R Wilkens; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Rachel T Palmieri; Daniel W Cramer; Marc T Goodman
Journal:  Cancer Causes Control       Date:  2010-06-18       Impact factor: 2.506

7.  Genetics and women's health issues--the commitment of EMS to women scientists and gender-associated disease topics.

Authors:  Kristine L Witt; Patricia G Moorman; Olga Kovalchuk; Nina Holland; Gladys Block; Paul R Andreassen
Journal:  Environ Mol Mutagen       Date:  2010 Oct-Dec       Impact factor: 3.216

8.  Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Authors:  Kathryn L Terry; Stalo Karageorgi; Yurii B Shvetsov; Melissa A Merritt; Galina Lurie; Pamela J Thompson; Michael E Carney; Rachel Palmieri Weber; Lucy Akushevich; Wei-Hsuan Lo-Ciganic; Kara Cushing-Haugen; Weiva Sieh; Kirsten Moysich; Jennifer A Doherty; Christina M Nagle; Andrew Berchuck; Celeste L Pearce; Malcolm Pike; Roberta B Ness; Penelope M Webb; Mary Anne Rossing; Joellen Schildkraut; Harvey Risch; Marc T Goodman
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-12

9.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Authors:  Weiva Sieh; Shannon Salvador; Valerie McGuire; Rachel Palmieri Weber; Kathryn L Terry; Mary Anne Rossing; Harvey Risch; Anna H Wu; Penelope M Webb; Kirsten Moysich; Jennifer A Doherty; Anna Felberg; Dianne Miller; Susan J Jordan; Marc T Goodman; Galina Lurie; Jenny Chang-Claude; Anja Rudolph; Susanne Krüger Kjær; Allan Jensen; Estrid Høgdall; Elisa V Bandera; Sara H Olson; Melony G King; Lorna Rodriguez-Rodriguez; Lambertus A Kiemeney; Tamara Marees; Leon F Massuger; Anne M van Altena; Roberta B Ness; Daniel W Cramer; Malcolm C Pike; Celeste Leigh Pearce; Andrew Berchuck; Joellen M Schildkraut; Alice S Whittemore
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

10.  Predictors of survival trajectories among women with epithelial ovarian cancer.

Authors:  Lauren C Peres; Sweta Sinha; Mary K Townsend; Brooke L Fridley; Beth Y Karlan; Susan K Lutgendorf; Eileen Shinn; Anil K Sood; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2019-12-12       Impact factor: 5.482
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.